Ulucakoy, R. K. Et Al. 2024. Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?. ARCHIVES OF RHEUMATOLOGY , no.3 , 368-374.

Ulucakoy, R. K., Kilic, A., Batibay, S., Cobanoglu, I. M., Şengün, D. N., Günendi, Z., ... Sepici Dinçel, A.(2024). Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?. ARCHIVES OF RHEUMATOLOGY , no.3, 368-374.

Ulucakoy, Rezan Et Al. "Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?," ARCHIVES OF RHEUMATOLOGY , no.3, 368-374, 2024

Ulucakoy, Rezan K. Et Al. "Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?." ARCHIVES OF RHEUMATOLOGY , no.3, pp.368-374, 2024

Ulucakoy, R. K. Et Al. (2024) . "Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?." ARCHIVES OF RHEUMATOLOGY , no.3, pp.368-374.

@article{article, author={Rezan Kocak Ulucakoy Et Al. }, title={Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?}, journal={ARCHIVES OF RHEUMATOLOGY}, year=2024, pages={368-374} }